BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells

被引:33
|
作者
Sharma, A. [1 ,2 ]
Singh, K. [1 ]
Mazumder, S. [1 ]
Hill, B. T. [3 ]
Kalaycio, M. [3 ]
Almasan, A. [1 ]
机构
[1] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA
[2] Cleveland State Univ, Cleveland, OH 44115 USA
[3] Cleveland Clin, Taussig Canc Inst, Dept Hematol Oncol & Blood Disorders, Cleveland, OH 44106 USA
来源
CELL DEATH & DISEASE | 2013年 / 4卷
基金
美国国家卫生研究院;
关键词
autophagy; MCL-1; BECN1; BIM; fludarabine resistance; CHRONIC LYMPHOCYTIC-LEUKEMIA; CYTOCHROME-C RELEASE; CASPASE ACTIVATION; UP-REGULATION; AUTOPHAGY; BCL-2; EXPRESSION; PHOSPHORYLATION; APOPTOSIS; DEATH;
D O I
10.1038/cddis.2013.155
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The purine analog fludarabine (Fd) is an essential therapeutic for chronic lymphocytic leukemia (CLL). Innate or acquired resistance to Fd is a significant clinical problem and is largely mediated by increased expression of BCL-2 family members. The antiapoptotic BCL-2 family proteins inhibit both apoptosis and autophagy, therefore, downregulation of antiapoptotic BCL-2 family proteins and enhanced autophagy must coexist in cells dying in response to an apoptosis inducing therapeutic. However, in the drug-resistant cells that have an increased dependence on antiapoptotic proteins, whether autophagy is also inhibited remains unclear. Here, we examined the role of the BCL-2 family in regulating cell death and autophagy in leukemic cell lines and their derivative isogenic Fd-resistant (FdR) cells. MCL-1 degradation following Fd treatment freed the proapoptotic effectors BIM and BECN1, thus leading to cell death-associated autophagy in Fd-sensitive cells. However, in FdR cells, low BIM expression and BECN1 sequestration by MCL-1 prevented cell death. Consistently, in sensitive cells inhibition of apoptosis using siBIM and of both the early-phase autophagy nucleation steps by siBECN1, shATG7 or 3-methyladenine and the late-phase autophagy by shLAMP2, significantly reduced Fd-induced cell death. Paradoxically, FdR cells were addicted to basal autophagy, which was dependent on AMP-activated protein kinase (AMPK) but not BECN1. Moreover, in FdR cells, inhibition of autophagy by shLAMP2, but not siBECN1, enhanced cell death. The BH3-mimetic obatoclax released BIM and BECN1 from MCL-1 in Fd-sensitive and BECN1 from MCL-1 in FdR cells, and was effective at killing both Fd-sensitive and - resistant leukemic cells, including primary CLL cells. Therefore, a differential regulation of autophagy through BECN1 and AMPK signaling in Fd-sensitive and - resistant cells determines the different possible outcomes of autophagy inhibition. These findings suggest effective means to overcome Fd resistance by induction of BIM-dependent apoptosis and activation of BECN1-dependent autophagy.
引用
收藏
页码:e628 / e628
页数:10
相关论文
共 50 条
  • [21] Autophagy-mediated HMGB1 release antagonizes apoptosis of gastric cancer cells induced by vincristine via transcriptional regulation of Mcl-1
    Zhan, ZhenZhen
    Li, Qun
    Wu, Ping
    Ye, Yan
    Tseng, Hsin-Yi
    Zhang, Linjie
    Zhang, Xu Dong
    AUTOPHAGY, 2012, 8 (01) : 109 - 121
  • [22] Overcoming multi-drug resistance in SCLC: a synergistic approach with venetoclax and hydroxychloroquine targeting the lncRNA LYPLAL1-DT/BCL2/BECN1 pathway
    Li, Shuxin
    Lv, Jianyi
    Li, Zhihui
    Zhang, Qiuyu
    Lu, Jing
    Huo, Xueyun
    Guo, Meng
    Liu, Xin
    Li, Changlong
    Wang, Jinghui
    Shi, Hanping
    Deng, Li
    Chen, Zhenwen
    Du, Xiaoyan
    MOLECULAR CANCER, 2024, 23 (01)
  • [23] Pyoluteorin derivatives induce Mcl-1 degradation and apoptosis in hematological cancer cells
    Doi, Kenichiro
    Gowda, Krishne
    Liu, Qiang
    Lin, Jyh-Ming
    Sung, Shen-Shu
    Dower, Christopher
    Claxton, David
    Loughran, Thomas P., Jr.
    Amin, Shantu
    Wang, Hong-Gang
    CANCER BIOLOGY & THERAPY, 2014, 15 (12) : 1688 - 1699
  • [24] ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation
    Russo, Maria
    Spagnuolo, Carmela
    Volpe, Silvestro
    Tedesco, Idolo
    Bilotto, Stefania
    Russo, Gian Luigi
    BIOCHEMICAL PHARMACOLOGY, 2013, 85 (07) : 927 - 936
  • [25] Characterisation of Mcl-1 cleavage during apoptosis of haematopoietic cells
    Clohessy, JG
    Zhuang, JG
    Brady, HJM
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (05) : 655 - 665
  • [26] Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
    Tolksdorf, Beatrice
    Zarif, Sina
    Eberle, Juergen
    Hazini, Ahmet
    Dieringer, Babette
    Jonsson, Franziska
    Kreppel, Florian
    Kurreck, Jens
    Fechner, Henry
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2021, 99 (09): : 1279 - 1291
  • [27] TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells
    Tian, Tian
    Li, Aimin
    Lu, Hong
    Luo, Ran
    Zhang, Mingzhi
    Li, Zhaoming
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 463 (04) : 638 - 643
  • [28] Mcl-1 Is Required for Melanoma Cell Resistance to Anoikis
    Boisvert-Adamo, Karen
    Longmate, Whitney
    Abel, Ethan V.
    Aplin, Andrew E.
    MOLECULAR CANCER RESEARCH, 2009, 7 (04) : 549 - 556
  • [29] Phosphorylation alters Bim-mediated Mcl-1 stabilization and priming
    Conage-Pough, Jason E.
    Boise, Lawrence H.
    FEBS JOURNAL, 2018, 285 (14) : 2626 - 2640
  • [30] Transcriptional regulation of Mcl-1 plays an important role of cellular protective effector of vincristine-triggered autophagy in oral cancer cells
    Hsieh, Ming-Ju
    Hsieh, Yi-Hsien
    Lin, Chiao-Wen
    Chen, Mu-Kuan
    Yang, Shun-Fa
    Chiou, Hui-Ling
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (04) : 455 - 470